News About: Pharm. Industry
130 pharmaceutical firms changed company names
A total of 130 domestic pharmaceutical firms, including Korea Green Cross and Sang-A, have changed their company names since the 1990s in a bid to renew corporate images toward the globalization era, according to stat...
Foreign-invested pharmaceutical firms suffer less damage from price cutbacks of drugs
The government is likely to attempt a smaller-than-expected price reduction on main drugs produced by the 22 multinational pharmaceutical firms, while some foreign-invested firms will suffer substantial dama...
Novartis Korea to name William Charles as new executive director
Recently, Novartis Korea appointed William Charles to serve its Business Franchise Primary Care and Mature Products Division, a core business of the company.
William Charles started his career as a sales person of ...
Hospitals may provide professional services for private clinics.
To relieve many ailing small and medium sized hospitals in their business management, 20 lawmakers including Rep. Kim Myeong-seop, the ex-president of KPA, raised a revision to the Medical Service Act, containing that...
980 drugs of 144 companies faced with 9.99% price slash.
The government post-supervision over the actual transaction drug prices in the markets brought out a massive NHI reimbursement price slash, in maximum up to 9.99% for 980 drugs supplied by 144 companies.
The superv...
Mukhtar Haider heads BMS Korea
BMS Korea has appointed Mukhtar Haider as its new president and he will assume the presidency next month.
Haider, a Pakistani doctor, joined Pakistan BMS as medical director and has held positions of regional direc...
Drug industry evading drug equivalency test works
The drug industry paid more interests in the bio-equivalent tests than the works on drug equivalency proof for general drugs, which ultimately resulted in number of generic drugs being so declined that the generic dru...
Health insurance allowance possible for Vioxx tablet to elderly patients over 65 ages from this...
Health insurance allowance possible for Vioxx tablet to elderly patients over 65 ages from this September
The Ministry of Health and Welfare recently revised terms for health insurance allowance for Vioxx tablet fr...
Corporate earnings figures lackluster in first half
With Korea's economy on the brink of recession, domestic pharmaceutical business conditions has been in the doldrums but the management of some pharmaceutical makers rolling out new drugs has seen better perfo...
Government urged to boost domestic R&D field via tax breaks, etc.
As part of measures to gear up the domestic pharmaceutical companies' competitiveness in the global BT sector, the government should push up with a variety of R&D investment stimulus measures including more tax benefi...
